Newron Pharmaceuticals S.p.A. (SWX:NWRN)
9.00
0.00 (0.00%)
Nov 12, 2026, 11:39 AM CET
Newron Pharmaceuticals Employees
Newron Pharmaceuticals had 27 employees as of December 31, 2025. The number of employees increased by 5 or 22.73% compared to the previous year. That makes Newron Pharmaceuticals the 37,486th largest employer in the world and 181st in Switzerland.
Employees
27
Change (1Y)
5
Growth (1Y)
22.73%
Revenue / Employee
356.15K CHF
Profits / Employee
-1.01M CHF
Market Cap
191.15M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 27 | 5 | 22.73% |
| Dec 31, 2024 | 22 | 0 | - |
| Dec 31, 2023 | 22 | -1 | -4.35% |
| Dec 31, 2022 | 23 | -2 | -8.00% |
| Dec 31, 2021 | 25 | 2 | 8.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bachem Holding AG | 2,725 |
| Idorsia | 487 |
| Basilea Pharmaceutica AG | 200 |
| Molecular Partners AG | 134 |
| Santhera Pharmaceuticals Holding AG | 94 |
| BioVersys AG | 38 |
| Xlife Sciences AG | 20 |
| Addex Therapeutics | 3 |
Newron Pharmaceuticals News
- 2 days ago - Newron Pharmaceuticals Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 4 weeks ago - Newron Pharma price target lowered to CHF 30 from CHF 44 at H.C. Wainwright - TheFly
- 4 weeks ago - Newron Pharmaceuticals Transcript: Investor update - Transcripts
- 4 weeks ago - Newron Pharmaceuticals Press release: Investor update - Filings
- 5 weeks ago - Newron Pharma price target lowered to CHF 19 from CHF 35 at Roth Capital - TheFly
- 7 weeks ago - Newron Pharmaceuticals Earnings release: H1 2026 - Filings
- 7 weeks ago - Newron Pharmaceuticals Quarterly report: H1 2026 - Filings
- 1 month ago - Newron Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts